These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35236179)

  • 21. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of the Intestine in the Development of Hyperuricemia.
    Yin H; Liu N; Chen J
    Front Immunol; 2022; 13():845684. PubMed ID: 35281005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of
    Xu Y; Cao X; Zhao H; Yang E; Wang Y; Cheng N; Cao W
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444825
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.
    Borghi C; Palazzuoli A; Landolfo M; Cosentino E
    Heart Fail Rev; 2020 Jan; 25(1):43-51. PubMed ID: 31745840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sugar-sweetened beverages, urate, gout and genetic interaction.
    Merriman TR; Dalbeth N; Johnson RJ
    Pac Health Dialog; 2014 Mar; 20(1):31-8. PubMed ID: 25928993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review on the fruit components affecting uric acid level and their underlying mechanisms.
    Zou F; Zhao X; Wang F
    J Food Biochem; 2021 Oct; 45(10):e13911. PubMed ID: 34426969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the anti-gout activity of chlorogenic acid: improvement on hyperuricemia and gouty inflammation.
    Meng ZQ; Tang ZH; Yan YX; Guo CR; Cao L; Ding G; Huang WZ; Wang ZZ; Wang KD; Xiao W; Yang ZL
    Am J Chin Med; 2014; 42(6):1471-83. PubMed ID: 25384446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of mechanism underlying hypouricemic effect of glucosyl hesperidin.
    Ota-Kontani A; Hirata H; Ogura M; Tsuchiya Y; Harada-Shiba M
    Biochem Biophys Res Commun; 2020 Jan; 521(4):861-867. PubMed ID: 31711647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.
    Bove M; Cicero AF; Veronesi M; Borghi C
    Vasc Health Risk Manag; 2017; 13():23-28. PubMed ID: 28223818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect and mechanism of total saponin of Dioscorea on animal experimental hyperuricemia.
    Chen GL; Wei W; Xu SY
    Am J Chin Med; 2006; 34(1):77-85. PubMed ID: 16437741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Historical review of gout and hyperuricemia investigations].
    Nakamura T
    Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Pimenta pseudocaryophyllus extracts on gout: Anti-inflammatory activity and anti-hyperuricemic effect through xantine oxidase and uricosuric action.
    Ferrari FC; Lemos Lima Rde C; Schimith Ferraz Filha Z; Barros CH; de Paula Michel Araújo MC; Antunes Saúde-Guimarães D
    J Ethnopharmacol; 2016 Mar; 180():37-42. PubMed ID: 26778678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phytochemicals in traditional Chinese medicine can treat gout by regulating intestinal flora through inactivating NLRP3 and inhibiting XOD activity.
    Liu ZQ; Sun X; Liu ZB; Zhang T; Zhang LL; Wu CJ
    J Pharm Pharmacol; 2022 Jul; 74(7):919-929. PubMed ID: 35640306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-hyperuricemic and nephroprotective effects of extracts from Chaenomeles sinensis (Thouin) Koehne in hyperuricemic mice.
    Zhang R; Zhan S; Li S; Zhu Z; He J; Lorenzo JM; Barba FJ
    Food Funct; 2018 Nov; 9(11):5778-5790. PubMed ID: 30327809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of intestinal microecology in the development of gout or hyperuricemia and the potential therapeutic targets.
    Dang K; Zhang N; Gao H; Wang G; Liang H; Xue M
    Int J Rheum Dis; 2023 Oct; 26(10):1911-1922. PubMed ID: 37606177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with gout differ from healthy subjects in renal response to changes in serum uric acid.
    Liu S; Perez-Ruiz F; Miner JN
    Joint Bone Spine; 2017 Mar; 84(2):183-188. PubMed ID: 27324603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triterpenoid acids from medicinal mushroom Inonotus obliquus (Chaga) alleviate hyperuricemia and inflammation in hyperuricemic mice: Possible inhibitory effects on xanthine oxidase activity.
    Luo LS; Wang Y; Dai LJ; He FX; Zhang JL; Zhou Q
    J Food Biochem; 2022 Mar; 46(3):e13932. PubMed ID: 34528276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics.
    Terkeltaub R; Bushinsky DA; Becker MA
    Arthritis Res Ther; 2006; 8 Suppl 1(Suppl 1):S4. PubMed ID: 16820043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uric acid lowering therapy in cardiovascular diseases.
    Volterrani M; Iellamo F; Sposato B; Romeo F
    Int J Cardiol; 2016 Jun; 213():20-2. PubMed ID: 26386814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperuricaemia and vascular risk: the debate continues.
    Landolfo M; Borghi C
    Curr Opin Cardiol; 2019 Jul; 34(4):399-405. PubMed ID: 30925517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.